FLAC vs CURV
Comparison between Frazier Lifesciences Acquisition Corp - Class A (FLAC, Company) and Torrid Holdings Inc (CURV, Company).
FLAC vs CURV - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
FLAC
$175M
CURV
$175M
Max Drawdown
Winner
FLAC
13.15%
CURV
96.90%
Sharpe Ratio
Winner
FLAC
-0.23
CURV
-0.54
5Y Beta
FLAC
N/A
CURV
0.90
Industry
FLAC
N/A
CURV
Apparel Retail
P/E Ratio
Winner
FLAC
-36.11
CURV
-23.75
Forward P/E
FLAC
N/A
CURV
1.92
Debt to Equity
FLAC
0.00%
Winner
CURV
-127.65%
Free Cash Flow Yield
Winner
FLAC
-0.12%
CURV
-12.51%
P/S Ratio
FLAC
N/A
CURV
0.18
P/B Ratio
FLAC
-15.02
CURV
N/A
FLAC vs CURV - Historical Returns
Returns include dividend reinvestment.
1M
FLAC
-1.40%
Winner
CURV
+32.67%
3M
FLAC
-0.70%
Winner
CURV
+59.20%
6M
FLAC
+0.41%
Winner
CURV
+93.20%
1Y
Winner
FLAC
+0.61%
CURV
-59.80%
5Y(CAGR)
FLAC
N/A
CURV
-39.62%
Max(CAGR)
Winner
FLAC
-4.92%
CURV
-39.62%
FLAC vs CURV - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | FLAC | CURV |
|---|---|---|
| 2026 | N/A | +87.74% |
| 2025 | N/A | -81.47% |
| 2024 | N/A | -12.98% |
| 2023 | N/A | +92.33% |
| 2022 | +0.71% | -71.04% |
| 2021 | -9.72% | -59.09% |
FLAC vs CURV Drawdown Comparison
The maximum drawdown for FLAC was -13.15%, occurring on Nov 9, 2022. This drawdown has not yet recovered.
The maximum drawdown for CURV was -96.90%, occurring on Dec 15, 2025. This drawdown has not yet recovered.
The current FLAC drawdown is -8.61%. The current CURV drawdown is -93.61%.
| Rank | FLAC | CURV |
|---|---|---|
| #1 | -13.15% Feb 8, 2021 - Nov 9, 2022 | -96.90% Aug 24, 2021 - Dec 15, 2025 |
| #2 | N/A | -16.74% Jul 6, 2021 - Aug 6, 2021 |
| #3 | N/A | -8.88% Aug 16, 2021 - Aug 24, 2021 |
| #4 | N/A | -1.36% Aug 11, 2021 - Aug 16, 2021 |
Correlation
Correlation between FLAC and CURV is -0.82 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
-0.82
-101
Select Stocks to Compare
Popular: FLAC vs SPYCURV vs SPY
More Comparisons
Compare with similar stocks